These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7865140)

  • 1. New drugs for the treatment of experimental alcoholism.
    Myers RD
    Alcohol; 1994; 11(6):439-51. PubMed ID: 7865140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of alcohol intake in diverse alcohol-preferring rat strains by the 5-HT2A antagonists amperozide and FG 5974.
    Overstreet DH; McArthur RA; Rezvani AH; Post C
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1448-54. PubMed ID: 9394117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential efficacy of serotonergic drugs FG5974, FG5893, and amperozide in reducing alcohol drinking in P rats.
    Lankford MF; Björk AK; Myers RD
    Alcohol; 1996; 13(4):399-404. PubMed ID: 8836330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone.
    Myers RD; Lankford MF
    Neuropsychopharmacology; 1996 Feb; 14(2):139-49. PubMed ID: 8822536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of high alcohol drinking in the inbred Fawn-Hooded (FH/Wjd) rat strain: implications for treatment.
    Overstreet DH; Rezvani AH; Cowen M; Chen F; Lawrence AJ
    Addict Biol; 2006 Sep; 11(3-4):356-73. PubMed ID: 16961764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol intake in high alcohol drinking (HAD) rats is suppressed by FG5865, a novel 5-HT1A agonist/5-HT2 antagonist.
    Long TA; Kalmus GW; Björk A; Myers RD
    Pharmacol Biochem Behav; 1996 Jan; 53(1):33-40. PubMed ID: 8848457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT2 receptor blockade by amperozide suppresses ethanol drinking in genetically preferring rats.
    Myers RD; Lankford MF; Björk A
    Pharmacol Biochem Behav; 1993 Jul; 45(3):741-7. PubMed ID: 8332634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addiction and the potential for therapeutic drug development.
    Janssen PA
    EXS; 1994; 71():361-70. PubMed ID: 8032167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amperozide, a 5-HT2 antagonist, attenuates craving for cocaine by rats.
    McMillen BA; Jones EA; Hill LJ; Williams HL; Björk A; Myers RD
    Pharmacol Biochem Behav; 1993 Sep; 46(1):125-9. PubMed ID: 8255902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone and amperozide modify chocolate and saccharin drinking in high alcohol-preferring P rats.
    Biggs TA; Myers RD
    Pharmacol Biochem Behav; 1998 Jun; 60(2):407-13. PubMed ID: 9632223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of the 5-HT2 receptor antagonist, ritanserin, to alter preference for alcohol in drinking rats.
    Myers RD; Lankford MF
    Pharmacol Biochem Behav; 1993 May; 45(1):233-7. PubMed ID: 8516364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irreversible suppression of alcohol drinking in cyanamide-treated rats after sustained delivery of the 5-HT2 antagonist amperozide.
    Myers RD; Lankford M; Björk A
    Alcohol; 1993; 10(2):117-25. PubMed ID: 8442888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ritanserin and alcohol abuse and dependence.
    Meert TF
    Alcohol Alcohol Suppl; 1994; 2():523-30. PubMed ID: 8974378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment of alcohol dependence: a review of the evidence.
    Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
    JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ritanserin in the treatment of alcohol dependence--a multi-center clinical trial. Ritanserin Study Group.
    Johnson BA; Jasinski DR; Galloway GP; Kranzler H; Weinreib R; Anton RF; Mason BJ; Bohn MJ; Pettinati HM; Rawson R; Clyde C
    Psychopharmacology (Berl); 1996 Nov; 128(2):206-15. PubMed ID: 8956382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism.
    Froehlich JC; Fischer SM; Dilley JE; Nicholson ER; Smith TN; Filosa NJ; Rademacher LC
    Alcohol Clin Exp Res; 2016 Sep; 40(9):1961-70. PubMed ID: 27469281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of the 5-HT2A antagonist amperozide on alcohol-induced poikilothermia in rats.
    Myers RD; Lankford M
    Pharmacol Biochem Behav; 1998 Jan; 59(1):91-5. PubMed ID: 9443541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ritanserin reduces abuse of alcohol, cocaine, and fentanyl in rats.
    Meert TF; Awouters F; Niemegeers CJ; Schellekens KH; Janssen PA
    Pharmacopsychiatry; 1991 Sep; 24(5):159-63. PubMed ID: 1775520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rats on the grog: novel pharmacotherapies for alcohol craving.
    McGregor IS; Gallate JE
    Addict Behav; 2004 Sep; 29(7):1341-57. PubMed ID: 15345269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prazosin + Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in P Rats with a Protracted History of Extensive Voluntary Alcohol Drinking, Dependence, and Multiple Withdrawals.
    Rasmussen DD; Kincaid CL; Froehlich JC
    Alcohol Clin Exp Res; 2015 Sep; 39(9):1832-41. PubMed ID: 26260061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.